Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.83 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.52 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4919758 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL1463911 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL4915851 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL4915881 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL4915709 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL4925671 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL3284074 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL2967294 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL7547097 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 | |
| SCHEMBL7543573 | 1.00 | CYP1A2 (0.83) | CYP1A2PAOXDGKAALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102532245-B | Ursolic acid derivative and preparation method thereof | UNIV PLA 3RD MILITARY MEDICAL | 2013-05-15 | — | — | CN | claimed |
| CN-102532245-A | Ursolic acid derivative and preparation method thereof | UNIV PLA 3RD MILITARY MEDICAL | 2012-07-04 | — | — | CN | claimed |
| US-12630579-B2 | Proteolysis targeting compound with tissue targeting capability and use thereof | TAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD (CN) | 2026-05-19 | — | — | US | disclosed |
| US-20260125362-A1 | TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY | ABBVIE BIOTECHNOLOGY LTD (BM) | 2026-05-07 | — | — | US | disclosed |
| US-20240270780-A1 | PROTEOLYSIS TARGETING COMPOUND WITH TISSUE TARGETING CAPABILITY AND USE THEREOF | TAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) | 2024-08-15 | — | — | US | disclosed |
| CN-117777053-A | Industrial production method of tianeptine | 山东诚汇双达药业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-112094266-B | Pyrrolopyridinone compound, preparation method, composition and application thereof | 中国科学院上海药物研究所 | 2023-03-21 | — | — | CN | disclosed |
| US-20220388985-A1 | TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY | ABBVIE BIOTECHNOLOGY LTD (BM) | 2022-12-08 | — | — | US | disclosed |
| CN-113563414-B | Tissue-targeted protein targeted degradation compound and application thereof | 泰比棣医药科技(石家庄)有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-108794358-B | Substituted benzenesulfonyl compounds and application thereof in preparing medicines | 中国人民解放军第二军医大学 | 2022-08-12 | — | — | CN | disclosed |
| US-20220242893-A1 | AMIDE-LINKED CONJUGATE COMPOUNDS AND USES THEREOF | UNIV FRASER SIMON (CA) | 2022-08-04 | — | — | US | disclosed |
| US-3992481-A | Fire retardant thermoplastic polymer compositions | STAUFFER CHEMICAL COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3992337-A | VINYL PHOSPHONATE - HALOGEN CONTAINING MONOMER COPOLYMER | STAUFFER CHEMICAL COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3992482-A | Fire retardant thermoplastic polymer compositions | STAUFFER CHEMICAL COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3991134-A | Fire retardant thermoplastic polymer compositions | STAUFFER CHEMICAL COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
| US-3991142-A | FROM TRIS(2,3-DIBROMOPYL)PHOSPHITE WITH PHOSPHORIC ACID | STAUFFER CHEMICAL COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
| US-3965216-A | BIS(HYDROCARBYL) VINYL PHOSPHONATE | STAUFFER CHEMICAL COMPANY (US) | 1976-06-22 | — | — | US | disclosed |
| US-3948842-A | Fire retardant polymeric additives of vinylidene halides with bis(hydrocarbyl) vinyl phosphonates and C1 -C20 alkylesters of acrylic and methacrylic acids | STAUFFER CHEMICAL COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
| US-3943085-A | HYDROCARBYL VINYL PHOSPHONATE-VINYL OR VINYLIDENE HALIDE, FLAME RETARDANT | STAUFFER CHEMICAL COMPANY (US) | 1976-03-09 | — | — | US | disclosed |
| US-3935149-A | BIS(HYDROCARBYL) VINYL PHOSPHONATE, VINYL OR VINYLIDENE HALIDE | STAUFFER CHEMICAL COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220388985-A1 | TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY | PARP14, PARP15, PARP16 | CYP1A2 4105/4885PAOX 862/4885DGKA 3006/4885 |
| US-20240270780-A1 | PROTEOLYSIS TARGETING COMPOUND WITH TISSUE TARGETING CAPABILITY AND USE THEREOF | ASGR1, ADRM1, PSMB11 | CYP1A2 1339/4885PAOX 1322/4885DGKA 2359/4885 |
| US-20220242893-A1 | AMIDE-LINKED CONJUGATE COMPOUNDS AND USES THEREOF | AADAC, DNPEP, NAALAD2 | CYP1A2 1300/4885PAOX 1690/4885DGKA 2258/4885 |
| US-20260125362-A1 | TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY | PARP14, PARP16, PARP11 | CYP1A2 4494/4885PAOX 756/4885DGKA 3939/4885 |
| US-12630579-B2 | Proteolysis targeting compound with tissue targeting capability and use thereof | ASGR1, ADRM1, LGALS3BP | CYP1A2 2953/4885PAOX 2423/4885DGKA 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.